Smithers Avanza, a contract research organization (CRO) supporting the pharmaceutical industry, announced that its Bioanalytical Services Division has Clinical Laboratory Improvement Amendments (CLIA) certification.
“Our clients’ requirements for independent, third-party testing expertise differ from phase to phase in their clinical trials,” said Ira DuBey, Executive Vice President, Bioanalytical Services Division, Smithers Avanza. “Obtaining CLIA certification verifies that we are a trusted laboratory resource throughout the drug development process, providing the right service and phase-appropriate expertise at the right moments for our clients.”
CLIA certification is overseen by the Centers for Medicare and Medicaid Services (CMS) and is mandatory for any laboratory performing testing that leads to the diagnosis or health assessment of patients.